Akebia Therapeutics, Inc. (AKBA) vs SIGA Technologies, Inc. (SIGA)

A side-by-side comparison of Akebia Therapeutics, Inc. and SIGA Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AKBA vs SIGA

growth of $100 · dividends reinvested · last 10y
AKBA -89.8% (-20.4%/yr)SIGA +74.3% (+5.7%/yr)SIGA compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020182020202220242026$10$174
AKBA SIGA

AKBA vs SIGA: by the numbers

  • •SIGA is the larger company ($236M vs $236M market cap).
  • •Both run net losses; SIGA's is the smaller (-5.14% vs -13.54% net margin).
  • •Both shrank revenue over the past five years; AKBA's decline was smaller (-0.26% vs -10.88% CAGR).
  • •SIGA pays a dividend (18.05% yield), while AKBA has no payments in the available dividend history.

Metrics side by side

Valuation

MetricAKBASIGA
Forward P/EN/A1.94
P/S ratio1.084.40
P/B ratio9.421.43
FCF yield17.05%N/A

Profitability

MetricAKBASIGA
Gross margin79.48%68.57%
Operating margin9.95%25.05%
Net margin-13.54%-5.14%
ROE-118.58%-1.67%
ROIC-7.08%-6.63%

Dividends

MetricAKBASIGA
Dividend yieldN/A18.05%

Growth (annualized)

MetricAKBASIGA
Revenue CAGR (5Y)-0.26%-10.88%
EPS CAGR (5Y)N/A-14.21%
Total return CAGR (5Y)-20.07%-6.59%

Frequently asked

Which has grown faster, AKBA or SIGA?
Neither grew: over the past five years both shrank revenue, with AKBA's decline the smaller — AKBA at a -0.26% CAGR versus SIGA at -10.88%.
Does AKBA or SIGA pay a bigger dividend?
SIGA pays a dividend (18.05% yield), while AKBA has no payments in the available dividend history.
How have AKBA and SIGA total returns compared?
Over the past 10 years, AKBA delivered -20.53% and SIGA delivered 5.71% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.